2024
Paul Yaworsky et al
Anti-WISP1 (MTX-463) as a Novel Potential Therapy for Idiopathic Pulmonary Fibrosis
Presented at the Keystone Symposia on Fibrosis: Inflammation, Drivers and Therapeutic Resolution, Whistler, BC, Canada

2024
Gabriela Dower, et al
Anti-WISP1 (MTX-463) as a Novel Potential Therapy for Idiopathic Pulmonary Fibrosis
Presented at The American Thoracic Society International Conference

2024
Benjamin T. Wilks, et al
Anti-EphrinB2 neutralizing antibody suppresses fibrosis in preclinical in vitro and in vivo models
Presented at The 4th Congress on the EPH/Ephrins System

2023
BM Kim et al
WISP1 Neutralization Suppresses Fibrosis in Preclinical in vivo and ex vivo Models
Presented at the Keystone Symposia on Fibrosis Pathogenesis and Resolution: From Mechanism to Therapies

2022
P Yaworsky et al
miR-15a Reprograms Activated Hepatic Stellate Cells Back Towards Quiescence by Targeting WISP1.
Presented at the 3^rd International Conference on Tissue Repair, Regeneration, and Fibrosis